Novan, Inc.

Durham, NC · Founded 2006 · Biotech · Acquired

Nitric oxide-releasing gel formulation for intravaginal self-administration to treat cervical HPV infections

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · novan.com.

Sector: Biotech
Headquarters: Durham, NC
Founded: 2006
Latest Form D: $30.4M, Dec 2015
Total capital: $55.9M

Federal grants: $1.5M; 4 awards · 2019–2023; Rank in peer group#191 of 326
Private capital raised: $54.5M; 6 Form D · last Dec 2015; 130 months since last filing
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 31; 9 pending · first 2016; Rank in peer group#3 of 326

Capital timeline

Latest events

Apr 2023Federal grantHealth and Human S · Phase II · Development of a nitric oxide-releasing antiviral gel for the treatment of cervical HPV infections and prevention of downstream malignancies in women$1
Apr 2021Federal grantHealth and Human S · Phase II · Development of a nitric oxide-releasing antiviral gel for the treatment of cervical HPV infections and prevention of downstream malignancies in women$126K
Mar 2020Federal grantHealth and Human S · Phase II · Development of a nitric oxide-releasing antiviral gel for the treatment of cervical HPV infections and prevention of downstream malignancies in women$1.1M
Aug 2019Federal grantHealth and Human S · Phase II · Development of a nitric oxide-releasing antiviral gel for the treatment of cervical HPV infections and prevention of downstream malignancies in women$223K
Dec 2015Private capital raisedForm D · SEC · 6th filing$30.4M
Aug 2014Private capital raisedForm D · SEC · 5th filing$10.3M
Mar 2014Private capital raisedForm D · SEC · 4th filing$3.5M
May 2012Private capital raisedForm D · SEC · 3rd filing$5.2M
Nov 2010Private capital raisedForm D · SEC · 2nd filing$3M
Jul 2009Private capital raisedForm D · SEC · 1st filing$2M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 326 peers

Line = median

Biotech · Molecule

Federal grantsBelow median
Granted patents#3 · top 1%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants

Nathan StaskoResearcherExecutive Officer, DirectorLinked by 3 patents
Mark SchoenfischResearcherExecutive Officer, DirectorLinked by 2 patents
F Neal HunterDirectorNamed in SEC Form D filings
F. Neal HunterDirectorNamed in SEC Form D filings
G Kelly MartinDirectorNamed in SEC Form D filings
G. Kelly MartinDirectorNamed in SEC Form D filings

Show all 13 people

John W PalmourDirectorNamed in SEC Form D filings
Richard Kelly PetersonExecutive OfficerNamed in SEC Form D filings
Robert A IngramDirectorNamed in SEC Form D filings
Robert P RuscherDirectorNamed in SEC Form D filings
Sean Kelly MurphyDirectorNamed in SEC Form D filings
W Kent GeerDirectorNamed in SEC Form D filings
W. Kent GeerDirectorNamed in SEC Form D filings

What it has protected

USPTO · 31 granted of 40

Nov 14, 2023GrantedTopical Compositions And Methods Of Using The SameUSPTOUS 11,813,284
Aug 15, 2023GrantedTopical Antiviral Compositions, Delivery Systems, And Methods Of Using The SameUSPTOUS 11,723,858
May 11, 2023PendingTopical Compositions And Methods Of Using The SameUSPTOApplication 18058320

Show all 40 patent records

Topical Compositions And Methods Of Using The SameNov 14, 2023 · US 11,813,284Granted
Topical Antiviral Compositions, Delivery Systems, And Methods Of Using The SameAug 15, 2023 · US 11,723,858Granted
Topical Compositions And Methods Of Using The SameMay 11, 2023 · Application 18058320Pending
Wound Dressings, Methods Of Using The Same And Methods Of Forming The SameFeb 21, 2023 · US 11,583,608Granted
Topical Compositions And Methods Of Using The SameDec 27, 2022 · US 11,534,382Granted
Nitric Oxide Releasing Suppositories And Methods Of Use ThereofJun 2, 2022 · Application 17675422Pending
Compositions, Systems, Kits, And Methods For Treating An InfectionApr 21, 2022 · Application 17408060Pending
Nitric Oxide Releasing Suppositories And Methods Of Use ThereofMar 29, 2022 · US 11,285,171Granted
Topical Compositions And Methods Of Using The SameMar 29, 2022 · US 11,285,098Granted
Compositions, Systems, Kits, And Methods For Treating An InfectionNov 9, 2021 · US 11,166,980Granted
Nitric Oxide Releasing Pharmaceutical CompositionsOct 21, 2021 · Application 17360852Pending
Tunable Nitric Oxide-releasing Macromolecules Having Multiple Nitric Oxide Donor StructuresSep 21, 2021 · US 11,124,476Granted
Nitric Oxide Releasing Pharmaceutical CompositionsAug 3, 2021 · US 11,077,194Granted
Topical Antiviral Compositions, Delivery Systems, And Methods Of Using The SameJun 22, 2021 · US 11,040,006Granted
Nitric Oxide Releasing Nail Coating Compositions, Nitric Oxide Releasing Nail Coatings, And Methods Of Using The SameFeb 23, 2021 · US 10,925,689Granted
Compositions For Treating Inflammation And Methods Of Treating The SameFeb 9, 2021 · US 10,912,743Granted
Combinations And Methods For The Treatment And/or Prevention Of Fungal InfectionsDec 1, 2020 · US 10,849,864Granted
Topical Compositions And Methods Of Using The SameNov 10, 2020 · US 10,828,323Granted
Topical Antiviral Compositions, Delivery Systems, And Methods Of Using The SameAug 11, 2020 · US 10,736,839Granted
Topical Compositions And Methods Of Using The SameJun 18, 2020 · Application 16623834Pending
Topical CompositionsDec 10, 2019 · US 10,500,220Granted
Tunable Nitric Oxide-releasing Macromolecules Having Multiple Nitric Oxide Donor StructuresOct 8, 2019 · US 10,435,357Granted
Topical Gels And Methods Of Using The SameAug 13, 2019 · US 10,376,538Granted
Topical Antiviral Compositions And Methods Of Using The SameJun 18, 2019 · US 10,322,081Granted
Topical Antiviral Compositions And Methods Of Using The SameJun 18, 2019 · US 10,322,082Granted
Anhydrous CompositionsApr 23, 2019 · US 10,265,334Granted
Topical Compositions And Methods Of Using The SameApr 16, 2019 · US 10,258,564Granted
Topical Compositions And Methods Of Using The SameMar 12, 2019 · US 10,226,483Granted
Topical Compositions And Methods Of Using The SameFeb 19, 2019 · US 10,206,947Granted
Tunable Nitric Oxide-releasing Macromolecules Having Multiple Nitric Oxide Donor StructuresFeb 5, 2019 · US 10,196,349Granted
Nitric Oxide Releasing Nail Coating Compositions, Nitric Oxide Releasing Nail Coatings, And Methods Of Using The SameJul 19, 2018 · Application 15743960Pending
Topical Compositions and Methods of Using the SameJan 2, 2018 · US 9,855,211Granted
Methods Of Manufacturing Topical Compositions And Apparatus For The SameSep 12, 2017 · US 9,757,397Granted
Nitric Oxide Releasing Bath Compositions And Methods Of Using The SameAug 31, 2017 · Application 15585617Pending
Topical Gels And Methods Of Using The SameAug 22, 2017 · US 9,737,561Granted
Nitric Oxide Releasing Bath Compositions And Methods Of Using The SameJun 6, 2017 · US 9,669,041Granted
Cosmetic Treatment With Nitric Oxide, Device For Performing Said Treatment And Manufacturing Method ThereforSep 8, 2016 · Application 15156889Pending
Topical CompositionsMar 22, 2016 · US 9,289,442Granted
Temperature Controlled Sol-gel Co-condensationFeb 23, 2016 · US 9,267,006Granted
Methods Of Modulating Steroid Hormone ActivityApr 23, 2015 · Application 14381377Pending

PRIMORDIAL GENETICS, INC.Similar federal contract value in Biotech · null in contracts
VANGUARD THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
COLLABORATIONS PHARMACEUTICALS INCSimilar federal contract value in Biotech · null in contracts
AXONIS THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
KIYATEC, LLCSimilar federal contract value in Biotech · null in contracts
Mitokinin, Inc.Similar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.